Zaslav Sells $113M of WBD Stock as Tax Reimbursement Clock Ticks on Paramount Deal

The numbers tell a clear story. Warner Bros. Discovery CEO David Zaslav is set to receive up to roughly $886.8 million if the Paramount Skydance deal closes. That's not just a bonus; it's a massive, time-sensitive windfall. The package breaks down to $517.2 million in equity, $34.2 million in cash severance, and a critical $335.4 million in tax reimbursements. The IRS rules make the last piece especially urgent: the reimbursement "significantly declines with the passage of time". If the deal closes in 2027, the filing notes, no tax reimbursement payment would be expected.

This creates a powerful incentive to close quickly. The smart money here is watching the clock. Yet, just before the deal announcement, Zaslav took a different view of the stock. He sold $113 million worth of WBD stock, a move that left him with roughly 7.2 million shares. That's over a third of his holdings, cashed out at a peak.

The setup is classic. A CEO is positioned to receive an enormous payout, but a key part of it vanishes if the deal drags on. At the same time, he's selling his own stake. This isn't skin in the game; it's a strategic exit. The thesis is that Zaslav is betting the deal will close this year to maximize his tax reimbursement, then walking away with a huge profit. His recent selling suggests he's already secured a personal gain and may be less concerned with the long-term health of the combined entity. The alignment of interest here is with the closing date, not the company's future.

Institutional Accumulation vs. CEO Selling

The smart money is sending mixed signals. While Warner Bros. Discovery CEO David Zaslav is cashing out, a different kind of insider is betting big on the deal's success. The filing reveals that Paramount CEO David Ellison and his billionaire father Larry Ellison made several unsolicited bids for WBD in September, offering "several hundred million dollars." That's deep-pocketed interest, not a casual stake. Larry Ellison, in particular, has backed the deal with a $40 billion personal equity commitment to reassure skeptical shareholders. This is institutional accumulation from the buyer's side, a vote of confidence in the combined entity's value.

Yet the stock market is pricing in doubt. Since the deal announcement, Paramount stock has given up all of its gains, trading down more than 10% over the past month. That's a stark contrast to Netflix, which saw its shares pop after exiting the bidding war. The market is looking past the headline numbers and focusing on the hurdles. The deal still needs antitrust approvals from the UK and EU, and it could face legal challenges from state attorneys general. These regulatory overhangs are weighing on the stock, making it a risky bet for retail traders.

The bottom line is a clear divergence. On one side, the CEO of the target company is selling his skin in the game, locking in a profit before the deal's uncertain timeline. On the other, the buyer's family is putting massive capital on the line, betting the deal closes. The stock's decline suggests the broader market is siding with the skeptics, not the insiders. For now, the smart money is watching the regulators, not the CEO's exit.

Valuation and Catalysts: What to Watch

The deal is valued at about $110 billion, a massive sum that hinges on a single, time-sensitive catalyst: regulatory approval. Paramount has stated it expects the transaction to close in the third quarter of this year. That timeline is critical, not just for the deal's structure, but for the CEO's personal payout.

The primary watchpoint is the regulatory process. While the deal has already secured antitrust approval from the US Department of Justice, it still needs clearance from the UK and EU competition authorities. It could also face legal challenges from state attorneys general. Any significant delay or unexpected hurdle here is a direct threat to the deal's closing date-and to Zaslav's windfall.

The direct impact on the payout is stark. The largest component of Zaslav's package, the $335.4 million in tax reimbursements, is calculated as of early March. Under IRS rules, that value "significantly declines with the passage of time". The filing notes that if the deal closes in 2027, no reimbursement would be expected. The smart money is watching the clock. Every week that passes without a green light from Brussels or London erodes the value of that key payout piece.

In practice, this creates a high-stakes race. The deal's success depends on regulators moving quickly, while the CEO's financial incentive is to see it done before the year turns. The market's recent skepticism, seen in Paramount's stock decline, suggests many are betting on a delay. For the insiders, the real catalyst is the regulatory calendar, not the stock price.